In Vitro Comparison Study Shows 99.3% Reduction in Bacteria Delivery After Simulated Touch Contamination

We are excited to announce the publication of an in vitro touch contamination study of the FDA-cleared Archimedes™ APD System in the peer-reviewed International Society for Peritoneal Dialysis (ISPD) Peritoneal Dialysis International (PDI) journal.

The study demonstrated a 99.3% reduction in bacterial delivery for the Archimedes™ system under simulated touch-contamination conditions compared with the Vantive/Baxter system evaluated in the study. As with any in vitro study, these findings reflect laboratory testing and should not be interpreted as demonstrating clinical outcomes.

Congratulations and thank you to Dr. James Sloand, MD, FACP, FASN, Jeremy Burton, Ph.D., Chris Munday, Ph.D., Dr. Arsh Jain, Dr. Osama El Shamy, and Rick Pendergraft, Ph.D. for their contributions to this work.

The study can be found here: https://journals.sagepub.com/doi/10.1177/08968608261461078

#SimergentPD #Simergent #ArchimedesPD #KidneyHealth #Kidneydisease #NKF #MyKidneyVoice #PeritonealDialysis #KidneyWarrior #EndStageRenalDisease (ESRD)